Bloomberg reported yesterday that the French drug agency is pulling pioglitazone from the market in view of its recent association with bladder cancer. I mentioned this here May 14. Pioglitazone is sold in the U.S. as Actos. I don’t expect the U.S. Food and Drug Administration to follow suit soon.
One response to “France Pulling Diabetic Drug Pioglitazone From Pharmacy Shelves”
Interesting piece! Actos is a terrible drug that should be banned in the United States, It causes bladder cancer and other serious side effects. This is a great resource: